Uluslararası Dergilerde Yayınlanan Bilimsel Makaleler

 

  1. Ozyigit, L. P., Aktas, E. C., Senbas, Z. A., Ozturk, A. B., Ozturk, E., Ergonul, M. Tabak L, Ferhanoglu B, Çetiner M, Deniz G. (2019). The role of atopy in the pathogenesis of bleomycin pulmonary toxicity. Respiratory Medicine.

 

  1. Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, Haydaroglu Sahin H, Ermis Turak E, Esen R, Comert M, Sadri S, Aslaner M, Uncu Ulu B, Karakus A, Selim Bapur D, Alacacioglu I, Aydin D, Tekinalp A, Namdaroglu S, Ceran F, Tarkun P, Kiper D, Çetiner M, Yenerel M, Demir AM, Yilmaz G, Terzi H, Atilla E, Malkan UY, Acar K, Ozturk E, Tombak A, Sunu C, Salim O, Alayvaz N, Sayan O, Ozan U, Ayer M, Gokgoz Z, Andic N, Kizilkilic E, Noyan F, Ozen M, Pepedil Tanrikulu F, Alanoglu G, Ozkan HA, Aslan V, Cetin G, Akyol Erikci A, Deveci B, Ersoy Dursun F, Dermenci H, Aytan P, Gunduz M, Karakus V, Ozlu C, Demircioglu S, Akay Yanar OM, Ozatli D, Undar L, Tiftik EN, Turkoz Sucak AG, Haznedaroglu I, Ozcan M, Sencan M, Tombuloglu M, Ozet G, Bilgir O, Turgut B, Ozcan MA, Payzın KB, Sonmez M, Ayyildiz O, Dal MS, Ertop S, Turgut M, Soysal T, Kaya E, Unal A, Pehlivan M, Atagunduz I, Tuglular Firatli T, Saydam G, Diz Kucukkaya R. A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia. Turk J Haematol. 2019 Jul 22. doi: 10.4274/tjh.galenos.2019.2018.0307.

 

  1. Madran B, Keske Ş, Tokça G, Dönmez E, Ferhanoğlu B, Çetiner M, Mandel NM, Ergönül Ö: Implementation of an antimicrobial stewardship program for patients with febrile neutropenia. Am J Infect Control. 2017 Nov 22. pii: S0196-6553(17) 31136-7. doi: 10.1016/j.ajic.2017.09.030. [Epub ahead of print]

 

  1. Öztürk E, Özyiğit LP, Öztürk AB, Akay MO, Çetiner M, Ferhanoğlu B. Rituximab desensitization in three patients with severe rituximab allergy. Curr Probl Cancer. 2017 Sep- Oct;41(5): 349-354

 

  1. Çavuşoğlu Y, Altay H, Çetiner M, Güvenç TS, Temizhan A, Ural D, Yeşilbursa D, Yıldırım N, Yılmaz MB. Iron deficiency and anemia in heart failure. Turk Kardiyol Dern Ars. 2017 Mar;45(Suppl 2):1-38

 

 

  1. Falay O, Öztürk E, Bölükbaşı Y, Gümüş T, Örnek S, Özbalak M, Çetiner M, Demirkol O, Ferhanoğlu B. Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma. Leuk Lymphoma. 2017 May;58(5):1114-1122

 

  1. Akpınar H, Çetiner M, Keshav S, Örmeci N, Törüner M. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report.

 

 

  1. Bekoz HS, Kantarcioglu B, Tecimer T, Uskent N, Çetiner M, Ferhanoglu B, Sargin D. Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report. Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):178-80

 

  1. Solak Y, Çetiner M, Siriopol D, Tarim K, Afsar B, Covic A, Kanbay M. Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease. Blood Purif. 2016 Jun 18;42(2):160-167.

 

  1. Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Çetiner M, Balaban B, Mandel NM, Esen T, Iwase A, Urman B, Oktem O. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro. Hum Reprod. 2015 Dec;30(12):2912-25.

 

  1. Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş, Başlar Z, Aydın Y, Soysal T, Ferhanoğlu B. Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis. Leuk Lymphoma. 2016 May;57(5):1211-4.

 

 

  1. Tokmak H, Ergönul O, Demirkol O, Çetiner M, Ferhanoglu B: Diagnostic contribution of (18) F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis. 2014; 19; 53-8

 

  1. Acar O, Esen T, Tecimer T, Çetiner M, Peker O, Musaoğlu A: Nonleukemic ureteral granulocytic sarcoma presenting with unilateral urinary obstruction and Hematuria. Case Rep Urol. 2013 2013;2013:861232. doi: 10.1155/2013/861232. Epub 2013 Aug 19.

 

 

  1. Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Çetiner M, Ferhanoglu B. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in relapse setting: two case reports and a review of literature. Transfusion. 2013 53 (7): 1586-93

 

  1. Ozalak M, Çetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B. Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience. Hematol Oncol 2011; 29: 1–6

 

  1. Kagusuz I, Tezcan H, Çetiner M, Kocakaya O, Uzay A, Bayik M. Bortezomib: A New Therapeutic Option for POEMS Syndrome. Eur J Haematol. 2009 Sep 3. 84(2):175-7

 

  1. Ciner S, Sucak GT, Kahraman SA, Akı SZ, Kocakahyaoglu B, Gultekin SE, Çetiner M, Haznedar R. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab. 2009;27(4):435-43

 

  1. Şener G, Eksioglu-Demiralp, E, Çetiner M., Ercan F, Yeğen BC. Beta-Glucan amoliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects. Eur J Pharmacol. 2006 Aug 7;542(1-3):170-8

 

 

  1. Şener, G., Eksioglu-Demiralp, E., Çetiner, M., Ercan, F., Şirvancı, S., Gedik, N., Yeğen, BC., L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol 22 (1), 47-60, 2006

 

  1. Çetiner M., Şener, G., Şehirli, Ö., Eksioglu-Demiralp, E., Ercan, F., Şirvancı, S., Gedik, N., Akpolat, S., Tecimer, T., Yeğen, BC., “Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death,” Toxicology and Applied Pharmacology 209 (1), 39-50 (2005)

 

  1. Özdemirli, M., Çetiner, M., “Non-B, non-T Neoplasms with Lymphoblast Morphology: Further Clarification and Classification,” Am J Surg Pathol, 28, 835-837 (2004).

 

  1. Çetiner, M., Adıgüzel, C., Argon, D., Ratip, S., Ekşioğlu-Demiralp, E., Tecimer, T., Bayık, M., “Hairy Cell Leukemia in Father and Son,” Med Oncol, 20, 375-378 (2003).

 

  1. Ratip, S., Odabaşı, Z., Kartı, S., Çetiner, M., Yeğen, C., Çerikçioğlu, N., Bayık, M., Korten, V., “Clinical Microbiological Case: Chronic Disseminated Candidiasis,” Clinical Microbiology and Infection, 8, 435-436 (2002).

 

  1. KARTI, S. S., ADIGÜZEL, C., YILMAZ, M., ÇETİNER M., RATİP, S., EKŞİOĞLU, E., … & BAYIK, M. COMPARISON OF TWO CRYOPRESERVATION METHOD ACCORDING TO STEM CELL VIABILITY AND COLONY FORMING CAPACITY. International Journal of Hematology and Oncology, 28(4), 171-177.

 

  1. Kartı, S., Ovalı, E., Ratip, S., Çetiner M., Direskeneli, H., Bayık, M., Akoğlu, T., “Effect of Interferon-alpha-2a on Neutrophil Adhesion and Phagocytosis in Chronic Myeloid Leukemia and Behcet’s Disease,” Clin Rheumatol, 21, 211-214 (2002).

 

  1. Ratip, S., Eryüksel, E., Odabaşı, Z., Çetiner, M., Özen, Y., Ovalı, E., … & Bayık, M. (2001). Effectivness of FLAG chemotheraphy in refractory or relapsed acute myeloid leukemia. Turk. J. Haematol, 18, 53-58.

 

  1. Ovalı, E., Ratip, S., Kibaroğlu, A., Tekelioğlu, Y., Çetiner, M., Kartı, S., Aydın, F., Bayık, M., Akoğlu, T. “Role of Hepatocyte Growth Factor in the Development of Dendritic Cells from CD 34+ Bone Marrow Cells”,  Haematologica, 85, 464-469 (2000).

 

  1. Kapıcıoğlu, S., Baki, A., Arslan, M., Çetiner, M., Cihanyurdu, N., “Effects of Omeprazole on Gallbladder Contraction in Humans”, Hepatogastroenterology, 47, 346-348 (2000).

 

  1. OVALI, E., ÇETİNER, M., RATİP, S., AYDIN, F., TEKELİOĞLU, Y., KARTI, S., … & AĞAOĞLU, N. (2000). Effects of angiotensin converting enzyme inhibitors in healthy rats and in rats with carbon tetrachloride-induced toxic hepatitis. Turkish Journal of Medical Sciences, 30(4), 321-326.

 

  1. Ratip, S., Budak-Alpdoğan, T., Alpdoğan, Ö., Çetiner, M., Karti, S., ELMACI, İ., & Bayik, M. (2000). Normal Pressure Hydrocephalus Associated with Chronic Alpha Interferon Treatment: A Case Report. Turk J Haematol, 17(1), 33-35.

 

  1. Kapıcıoğlu, S., Çetiner, M., & Baki, A. (1999). Measurement of unconjugated hyperbilirubinemia in Gilbert’s syndrome during compulsory fasting. Marmara Medical Journal, 12(4), 171-174.

 

  1. Kapicioglu, S., Çetiner, M., & Arslan, M. (1999). Action of Buffered Aspirin (Alka-Seltzer)’on Gastric Mucosal Injury in Humans. Annals of Medical Sciences, 8, 48-51.

 

  1. Çetiner, M., Ratip, S., Ovalı, E., Kartı, S., Bayık, M., & Akoğlu, T. (1998). Bone marrow transplantation data for marmara university school of medicine: 1989-1998. Marmara Medical Journal, 11(4), 204-209.

 

  1. ÇETINER, M., OVALI, E., YIGITER, Y., & KAPICIOGLU, S. (1996). The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompansated cirrhosis and healthy volunteers. Turk J Gastroeruerol, 7, 22-26.

 

 

Uluslararası Kongrelerde Sunulan Bildiriler

 

  1. Beksac M, Özdemir E, Yağcı M, Büyükkeçeci F, Çağırgan S, Özdoğu H, kalayoğlu Beşışık S, Demirkan F, Üskent N, Kaygusuz I, Fıratlı Tuğlular T, Göker H, Özcan M.A., Çetiner M, Akyol Erikçi A, Turgut B. Clinical experience with lenalidomide and dexamethasone (Len + dex) for the treatment of patients with relapsed / refractory Multiple Myeloma (MM): Safety and efficacy data from the Turkish Compassionate use program (CUP). 13th International Myeloma Workshop. May 3-6 2011, Paris, France.

 

  1. Cetiner M, Ferhanoglu B, Aydin F, Molinas N, Tuzuner N, Ozbalak M, Kaygusuz I. Rituximab-CHOP versus CHOP alone in patients with diffuse large B cell Lymphoma. 50th Anniversary of the Discovery of Burkitt Lymphoma. 25-27 February 2008 Kampala, Uganda

 

  1. Çetiner S, Türköz Sucak G, Akı ŞZ, Kocakahyaoğlu B, Kahraman S, Araç M, Çetiner M, Delilbaşı E, Haznedar R. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. 1st International Lymphoma-Leukemia-Myeloma Congress, Fethiye/Muğla, 24-27 May 2007

 

  1. Adıgüzel C, Kaygusuz I, Birtaş Ateşoglu E, Noyan F, Çetiner M, Demiralp E, Fıratlı-Tuğlular T, Bayık M. Chronic Myelogenous Leukemia occurring in mother and son. 1st International Lymphoma-Leukemia-Myeloma Congress, Fethiye/Muğla, 24-27 May 2007

 

  1. Mustafa Cetiner, Taflan Salepci, Elif Birtas Atesoglu, Mahmut Gumus, Aslihan Guven, Levent Undar, Tulin Firatli Tuglular, Rituximab-CHOP Versus CHOP Alone in Patients with Diffuse Large B Cell Lymphoma. American Society of Hematology (ASH) meeting, Orlando, 2006 (Abstract #4708 appears in Blood, Volume 108, issue 11, November 16, 2006)

 

  1. Atasoy BM, Cetiner M, Argon A, Yavuz MN, Firatli Tuglular T, Sengoz M, Bayik M, Ovali E. The protective effect of amifostine on irradiated haemapoetic cells. ECCO 13 the European Cancer Conference, Paris, 2005

 

  1. Singhal, S., Cetiner, M., Gordon, A., Evens, M., Tallman, M., Williams, S., Winter, J., Meagher, R., Mehta, J., “Factors Affecting Survival After Submyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies,” 41th American Society of Clinical Oncology Meeting (ASCO), Vol XXIII, 600s, Orlando, Florida, 2005.

 

  1. Mehta, J., Çetiner, M., Gordon, A., Evens, M., Tallman, M., Williams, S., Winter, J., Meagher, R., Singhal, S., “Effect of Impaired Renal Function on the Outcome of Submyeloablative Allogeneic Hematopoietic Stem cell Transplantation in Patients with Hematological Malignancies,” 41th American Society of Clinical Oncology Meeting (ASCO), Vol XXIII, 601s, Orlando, Florida, 2005.

 

  1. Şener, G., Çetiner, M., Ekşioğlu-Demiralp, E., Ercan, F., Şirvancı, S., Gedik, N., Yeğen, BÇ., “Taurine Protects Against Methotrexate-induced Hepatotoxicity and Inhibits Leucocyte Apoptosis,” American Gastrointestinal Association Digestive Disease Week, Chicago, 2005.

 

  1. Şener, G., Çetiner, M., Ekşioğlu-Demiralp, E., Ercan, F., Şirvancı, S., Gedik, N., Yeğen, BÇ., “Beta glucan reduces methotrexate-induced intestinal damage in rats.” XXXth World Congress of the International Society of Hematology, İstanbul, 2005.

 

  1. Birtaş, E., Odabaşı, Z., Fıratlı Tuğlular, T., Adıgüzel, C., Kaygusuz, I., Noyan, F., Çetiner, M., Korten, V., Epidemiology of bacterial infections febrile neutropenic patients having hematological malignancies in Marmara University Hospital, Istanbuş, Türkiye. .” XXXth World Congress of the International Society of Hematology, İstanbul, 2005.

 

  1. Noyan, F., Birtaş, E., Adıgüzel, C., Kaygusuz, I., Çetiner, M., Fıratlı Tuğlular, T., Bayık, M., A VAD therapy resistant multiple myeloma transformed from CLL. XXXth World Congress of the International Society of Hematology, İstanbul, 2005.

 

  1. Çetiner, M., Kalaça, S., Birtaş, E., Yazgan, Ç., Kuşçu, K., Kalayoğlu Beşışık, S., Sargın, D., Ferhanoğlu, B., Fıratlı Tuğlular, T., Bayık, M., Age and gender associated differences in the quality of Turkish adult hematopoietic stem cell transplantation recipients. XXXth World Congress of the International Society of Hematology, İstanbul, 2005.

 

  1. Çetiner, M., Kalaça, S., Ratip, S., Yazgan, Ç., Adıgüzel, C., Kalayoğlu-Beşışık, S., Argon, D., Kaygusuz, I., Aktuğlu, G., Bayık, M., “Quality of Life Assessment of Haematopoietic Stem cell Transplantationpatients in İstanbul: a Pilot Study,” 30th Annual Meeting of the European Group for Blood and Marrow Transplantation, Barcelona, Bone Marrow Transplantation, Vol. XXXIII, 2004

 

  1. Kaygusuz, I., Sönmezoğlu, M., Öneş, T., Dede, T., Çetiner, M., Aktaş, S., Bayık, M., “Factors Affecting the Red Cell Survival in Patients with Receiving Multiple Transfusion,” International Society of Blood Transfusion (ISBT) VII. European Congress, Paris, Vol. VIII, 2001

 

  1. Ratip, S., Akın, H., Ekenel, M., Çetiner, M., Şeker, M., Bayık, M., “Relationship Between Thrombocytopenia and Severity and Duration of Crush Injury in Earthquake Victims,” 5th Annual Meeting of the European Haematology Association, Birmingham, The Hematology Journal, Vol. I, 141, 2000

 

  1. Kibaroğlu A, Ekşioğlu-Demiralp E, Ratip S, Aktam M, Tatlıcı G,  Çetiner M,  Kartı S, Bayık M, Akoğlu T. Increased Adhesion of B-chronic lymphocytic cells to the Bone Marrow: Role of Bone Marrow Microenviroments. IVth Congress of the European Haematology Association, Barcelona, Hematologica, Vol. 84, 163, 1999

 

  1. Kartı, S., Ovalı, E., Ratip, S., Odabaşı, Z., Sarı, H., Çetiner, M., Yavuz, S., Yavuz, Ş., Fresko, I., Dreskeneli, H., Bayık, M., Akoğlu, T., “The Effects of Alpha Interferon on Neutrophil Functions in Patients with Behçet’s Disease,” 8th International Congress on Behçet’s Disease. Emilia, Italy, 1998

 

  1. Ovalı, E., Çetiner, M., Tekelioğlu, Y., Köseoğlu, F., “ The Early Effects of Whole Blood Transfusion on Immune Functions in Healthy Volunteers, ” XIIIth Meeting of the International Society of Haematology (European & African Division), İstanbul, 1995.

 

 

  1. Ülkü, N., Çetiner, M., Genç, N., Aksu, N., “Three years Follow-up of Hypertensive Patients seen in MEBSEM Ankara Hypertension & Lipid Unit,” Turkish-German Joint Meeting on Hypertension & Atherosclerosis, Antalya, 1996.

 

  1. Çetiner, M., Ülkü, N., Aksu, N., Genç, N., “Coronary Risk Factors Among Recently Diagnosed Essential Hypertensive Cases”, Turkish-German Joint Meeting on Hypertension & Atherosclerosis, Antalya, 1996.